A detailed history of North Crest Asset Manangement, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, North Crest Asset Manangement, LLC holds 2,212 shares of EW stock, worth $204,211. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,212
Holding current value
$204,211
% of portfolio
0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

BUY
$72.54 - $95.56 $160,458 - $211,378
2,212 New
2,212 $211,000
Q2 2023

Jul 21, 2023

BUY
$81.41 - $94.33 $569 - $660
7 Added 0.28%
2,498 $235,000
Q1 2023

Apr 25, 2023

BUY
$74.26 - $84.51 $184,981 - $210,514
2,491 New
2,491 $206,000
Q2 2022

Jul 18, 2022

BUY
$86.5 - $128.27 $194,625 - $288,607
2,250 New
2,250 $214,000
Q1 2022

Apr 18, 2022

SELL
$101.96 - $128.34 $229,410 - $288,765
-2,250 Closed
0 $0
Q4 2021

Feb 09, 2022

BUY
$106.37 - $130.68 $239,332 - $294,030
2,250 New
2,250 $291,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $57.1B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track North Crest Asset Manangement, LLC Portfolio

Follow North Crest Asset Manangement, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Crest Asset Manangement, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Crest Asset Manangement, LLC with notifications on news.